These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 27020328)

  • 41. Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic.
    Volpin F; Casaos J; Sesen J; Mangraviti A; Choi J; Gorelick N; Frikeche J; Lott T; Felder R; Scotland SJ; Eisinger-Mathason TSK; Brem H; Tyler B; Skuli N
    Oncogene; 2017 May; 36(21):3037-3047. PubMed ID: 27941882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.
    Piroth MD; Gagel B; Pinkawa M; Stanzel S; Asadpour B; Eble MJ
    Strahlenther Onkol; 2007 Dec; 183(12):695-702. PubMed ID: 18040615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
    Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
    J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of glycemia on survival of glioblastoma patients treated with radiation and temozolomide.
    Tieu MT; Lovblom LE; McNamara MG; Mason W; Laperriere N; Millar BA; Ménard C; Kiehl TR; Perkins BA; Chung C
    J Neurooncol; 2015 Aug; 124(1):119-26. PubMed ID: 26015297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO).
    Scoccianti S; Krengli M; Marrazzo L; Magrini SM; Detti B; Fusco V; Pirtoli L; Doino D; Fiorentino A; Masini L; Greto D; Buglione M; Rubino G; Lonardi F; Migliaccio F; Marzano S; Santoni R; Ricardi U; Livi L
    Radiol Med; 2018 Jan; 123(1):48-62. PubMed ID: 28879459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Change in platelet levels during radiotherapy with concurrent and adjuvant temozolomide for the treatment of glioblastoma: a novel prognostic factor for survival.
    Williams M; Liu ZW; Woolf D; Hargreaves S; Michalarea V; Menashy R; Kooner I; Wilson E
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1683-8. PubMed ID: 22644996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Recent advances in the medical treatment of glioma-temozolomide].
    Nishikawa R
    No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
    [No Abstract]   [Full Text] [Related]  

  • 49. Temozolomide for high grade glioma.
    Hart MG; Garside R; Rogers G; Stein K; Grant R
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007415. PubMed ID: 23633341
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A restricted cell population propagates glioblastoma growth after chemotherapy.
    Chen J; Li Y; Yu TS; McKay RM; Burns DK; Kernie SG; Parada LF
    Nature; 2012 Aug; 488(7412):522-6. PubMed ID: 22854781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-angiogenic therapy for high-grade glioma.
    Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.
    Brandes AA; Franceschi E; Tosoni A; Benevento F; Scopece L; Mazzocchi V; Bacci A; Agati R; Calbucci F; Ermani M
    Cancer; 2009 Aug; 115(15):3512-8. PubMed ID: 19514084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population-based study of pseudoprogression after chemoradiotherapy in GBM.
    Roldán GB; Scott JN; McIntyre JB; Dharmawardene M; de Robles PA; Magliocco AM; Yan ES; Parney IF; Forsyth PA; Cairncross JG; Hamilton MG; Easaw JC
    Can J Neurol Sci; 2009 Sep; 36(5):617-22. PubMed ID: 19831132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cisplatinum and BCNU chemotherapy in primary glioblastoma patients.
    Silvani A; Gaviani P; Lamperti EA; Eoli M; Falcone C; Dimeco F; Milanesi IM; Erbetta A; Boiardi A; Fariselli L; Salmaggi A
    J Neurooncol; 2009 Aug; 94(1):57-62. PubMed ID: 19212704
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
    World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antitumor treatment efficacy by targeting epidermal growth factor receptor and vascular endothelial growth factor receptor-2 in an orthotopic human glioblastoma model.
    Yi D; Hua TX; Lin HY; Kui CL; Ning LX; Wang ZZ
    J Neurooncol; 2011 Aug; 104(1):93-101. PubMed ID: 21140283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma.
    Barker CA; Chang M; Chou JF; Zhang Z; Beal K; Gutin PH; Iwamoto FM
    J Neurooncol; 2012 Sep; 109(2):391-7. PubMed ID: 22688802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.
    Stupp R; Hegi ME; Neyns B; Goldbrunner R; Schlegel U; Clement PM; Grabenbauer GG; Ochsenbein AF; Simon M; Dietrich PY; Pietsch T; Hicking C; Tonn JC; Diserens AC; Pica A; Hermisson M; Krueger S; Picard M; Weller M
    J Clin Oncol; 2010 Jun; 28(16):2712-8. PubMed ID: 20439646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion.
    Stummer W; van den Bent MJ; Westphal M
    Acta Neurochir (Wien); 2011 Jun; 153(6):1211-8. PubMed ID: 21479583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.
    Minniti G; Amelio D; Amichetti M; Salvati M; Muni R; Bozzao A; Lanzetta G; Scarpino S; Arcella A; Enrici RM
    Radiother Oncol; 2010 Dec; 97(3):377-81. PubMed ID: 20855119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.